Enzalutamide
Enzalutamide (brand name Xtandi) is a synthetic non-steroidal antiandrogen (NSAA) which was developed by the pharmaceutical company Medivation for the treatment of metastatic castration-resistant prostate cancer. Medivation has reported up to an 89% decrease in serum prostate specific antigen (PSA) levels after a month of taking the drug. Research suggests that enzalutamide may also be effective in the treatment of certain types of breast cancer. In August 2012, the United States (U.S.) Food and Drug Administration (FDA) approved enzalutamide for the treatment of castration-resistant prostate cancer.
Wikipage redirect
primaryTopic
Enzalutamide
Enzalutamide (brand name Xtandi) is a synthetic non-steroidal antiandrogen (NSAA) which was developed by the pharmaceutical company Medivation for the treatment of metastatic castration-resistant prostate cancer. Medivation has reported up to an 89% decrease in serum prostate specific antigen (PSA) levels after a month of taking the drug. Research suggests that enzalutamide may also be effective in the treatment of certain types of breast cancer. In August 2012, the United States (U.S.) Food and Drug Administration (FDA) approved enzalutamide for the treatment of castration-resistant prostate cancer.
has abstract
Enzalutamid ist ein Inhibitor ...... alen Vertrieb von Enzalutamid.
@de
Enzalutamida es un medicamento ...... encia Europea de Medicamentos.
@es
Enzalutamide (brand name Xtand ...... ion-resistant prostate cancer.
@en
L'Enzalutamide, noto precedent ...... e con la Astellas Pharma Inc..
@it
L’enzalutamide est une molécul ...... ions peuvent parfois survenir.
@fr
エンザルタミド（英語: Enzalutamide、商品名：イ ...... 性去勢抵抗性前立腺癌」について2014年12月に承認された。
@ja
ATC prefix
ATC suffix
Bioavailability
CAS number
915087-33-1
ChEBI
FDA UNII code
93T0T9GKNU
IUPAC name
4-(3-(4-Cyano-3-(trifluorometh ...... yl)-2-fluoro-N-methylbenzamide
@en
PubChem
thumbnail
Wikipage page ID
18,066,455
Wikipage revision ID
742,114,943
ChemSpiderID
13,093,347
elimination half-life
-777600.0
IUPHAR ligand
legal US
licence US
metabolism
protein bound
routes of administration
smiles
StdInChIKey
WXCXUHSOUPDCQV-UHFFFAOYSA-N
synonyms
tradename
subject
hypernym
comment
Enzalutamid ist ein Inhibitor ...... alen Vertrieb von Enzalutamid.
@de
Enzalutamida es un medicamento ...... encia Europea de Medicamentos.
@es
Enzalutamide (brand name Xtand ...... ion-resistant prostate cancer.
@en
L'Enzalutamide, noto precedent ...... e con la Astellas Pharma Inc..
@it
L’enzalutamide est une molécul ...... ions peuvent parfois survenir.
@fr
エンザルタミド（英語: Enzalutamide、商品名：イ ...... 性去勢抵抗性前立腺癌」について2014年12月に承認された。
@ja
label
Enzalutamid
@de
Enzalutamida
@es
Enzalutamide
@en
Enzalutamide
@fr
Enzalutamide
@it
エンザルタミド
@ja
wasDerivedFrom
depiction
isPrimaryTopicOf
name
Enzalutamide (INN,USAN)
@en